Advertisement

90-Year-Old British Grandmother Is First In World To Get Pfizer Vaccine Outside Trial

Follow The Hawk on Google News+ Follow

Advertisement


London: Margaret Keenan, a 90-year-old grandmother from Britain, has become the first person in the world to receive the Pfizer COVID-19 vaccine outside of a trial following its rapid clinical approval.

An early riser, Keenan received the jab at her local hospital in Coventry, central England, on Tuesday morning at 0631 GMT, a week before she turns 91. Britain began rolling out the COVID-19 vaccine developed by Pfizer and BioNTech on Tuesday, the first Western country to start vaccinating its general population in what was hailed as a decisive watershed in defeating the coronavirus.

Advertisement

The mass inoculation will fuel hope that the world may be turning a corner in the fight against a pandemic that has crushed economies and killed more than 1.5 million, although ultra-cold storage and tricky logistics will limit its use for now. "I feel so privileged to be the first person vaccinated against Covid-19," said Keenan.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"It's the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year." Britain's Medicines and Healthcare products Regulatory Agency (MHRA) granted emergency use approval to the Pfizer-BioNTech vaccine, which they say is 95% effective in preventing illness, in record time - just 23 days since Pfizer published the first data from its final stage clinical trial.

The approval of a jab for use almost exactly a year since the novel coronavirus emerged in Wuhan, China, is a triumph for science, Pfizer boss Albert Bourla and his German biotechnology partner BioNTech.

But the breakneck speed at which approval was given drew criticism from Brussels where, in an unusually blunt statement, the European Union's drugs regulator said its longer procedure to approve vaccines was more appropriate as it was based on more evidence and required more checks. British leaders said that, while they would love to get a jab themselves, priority had to be given to those most in need - the elderly, those in care homes and health workers. —Reuters

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST